CDKN2A and Miyoshi myopathy: Dysregulation of DNA methylation is one of the most studied epigenetic mechanisms in DR of different types of cancers including MM as evidenced by higher frequency of hypermethylation of some tumor suppressor genes, such as CDKN2A and CDKN2B, in relapsed than in newly diagnosed MM patients [17].